Organization · Private Equity
Forward Equity Partners
Forward Equity Partners is a cross-border private equity firm specializing in global healthcare and life sciences investments, partnering with innovative companies in these sectors.
Overview
What Forward Equity Partners does
What Forward Equity Partners is
Forward Equity Partners is a cross-border private equity firm specializing in global healthcare and life sciences investments, partnering with innovative companies in these sectors.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Private Equity
- Structured capabilities
- Funder
- Last reviewed
- April 28, 2026
Official channels
Find Forward Equity Partners elsewhere
Open the official website or a supported primary organization account.
Capability profile
Forward Equity Partners as a funder
Investment thesis
Forward Equity Partners is dedicated to investing in innovative healthcare and life sciences companies that provide essential technology and infrastructure for human health advancement.
Focus narrative
The firm targets innovative companies that offer disruptive technologies and services in the healthcare and life sciences sectors, aiming to advance human health.
Focus and fit
- Regions
- Global · Asia
Availability
- Currently deploying
- Not published
Portfolio and track record
- Recorded notable exits
- Cognate BioServices, Genopis, Inc., WCCT Global, Inc., and SillaJen, Inc.
Portfolio context
Notable portfolio companies include Cognate BioServices, a leading contract development and manufacturing organization for cell and gene therapy products; Genopis, Inc., specializing in plasmid DNA; WCCT Global, Inc., an early-stage clinical research organization; and SillaJen, Inc., focused on oncolytic virus immunotherapeutics. Current investments include CHA Vaccine Institute, Riva Therapeutics, Genosco, and CMG Pharmaceutical.
Common questions
What to know about Forward Equity Partners
Upseed classifies Forward Equity Partners under the Private Equity organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 28, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.